| Dr Mark R Keane, MD | |
|
415 6th St, Lewiston, ID 83501-2431 | |
| (208) 750-7474 | |
| Not Available |
| Full Name | Dr Mark R Keane |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 30 Years |
| Location | 415 6th St, Lewiston, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427044643 | NPI | - | NPPES |
| 805433500 | Medicaid | ID | |
| 7088867 | Medicaid | WA | |
| 8239543 | Medicaid | WA | |
| 128039 | Other | WA | L & I WA |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Regional Medical Center | Lewiston, ID | Hospital |
| St Marys Hospital And Clinics | Cottonwood, ID | Hospital |
| Dayton General Hospital | Dayton, WA | Hospital |
| Tri-state Memorial Hospital | Clarkston, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Joseph Hospital Llc | 8325325806 | 39 |
| St Joseph Hospital Llc | 8325325806 | 39 |
News Archive
St. Jude Medical, Inc., a global medical device company, today reported sales and net earnings for the second quarter ended July 3, 2010.
Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced positive results from the company's PEARL-HF study, a Phase 2 clinical trial of the company's lead compound, RLY5016. These data were presented by Dr. Bertram Pitt, Professor of Medicine Emeritus, Division of Medicine at the University of Michigan School of Medicine, during the Late-Breaking Clinical Trials Session in an oral presentation titled "The PEARL-HF (Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Dose To Evaluate the Effects of RLY5016 in Heart Failure Patients) Trial" at the 14th Annual Scientific Meeting of the Heart Failure Society of America held in San Diego, CA September 13-15, 2010.
More than half of people with acute COVID-19 infection continue to have persistent fatigue 10 weeks after their initial illness, according to a new study published November 9 in the open-access journal PLOS ONE by Liam Townsend of Trinity College Dublin, Ireland and colleagues.
Artel Thorpe Sr. of Jackson, Tennessee, recently became the first person in the United States to undergo a new, less invasive surgical technique for implanting a left ventricular assist device (LVAD) heart pump since it was granted Federal Drug Administration approval on July 11.
District of Columbia Mayor Anthony A. Williams today announced the launch of a comprehensive community outreach campaign to encourage annual child health assessments and immunizations.
› Verified 9 days ago
| Entity Name | St Joseph Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790816262 PECOS PAC ID: 2961497235 Enrollment ID: O20041220001093 |
News Archive
St. Jude Medical, Inc., a global medical device company, today reported sales and net earnings for the second quarter ended July 3, 2010.
Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced positive results from the company's PEARL-HF study, a Phase 2 clinical trial of the company's lead compound, RLY5016. These data were presented by Dr. Bertram Pitt, Professor of Medicine Emeritus, Division of Medicine at the University of Michigan School of Medicine, during the Late-Breaking Clinical Trials Session in an oral presentation titled "The PEARL-HF (Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Dose To Evaluate the Effects of RLY5016 in Heart Failure Patients) Trial" at the 14th Annual Scientific Meeting of the Heart Failure Society of America held in San Diego, CA September 13-15, 2010.
More than half of people with acute COVID-19 infection continue to have persistent fatigue 10 weeks after their initial illness, according to a new study published November 9 in the open-access journal PLOS ONE by Liam Townsend of Trinity College Dublin, Ireland and colleagues.
Artel Thorpe Sr. of Jackson, Tennessee, recently became the first person in the United States to undergo a new, less invasive surgical technique for implanting a left ventricular assist device (LVAD) heart pump since it was granted Federal Drug Administration approval on July 11.
District of Columbia Mayor Anthony A. Williams today announced the launch of a comprehensive community outreach campaign to encourage annual child health assessments and immunizations.
› Verified 9 days ago
| Entity Name | St Joseph Hospital Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205368404 PECOS PAC ID: 8325325806 Enrollment ID: O20170606002496 |
News Archive
St. Jude Medical, Inc., a global medical device company, today reported sales and net earnings for the second quarter ended July 3, 2010.
Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced positive results from the company's PEARL-HF study, a Phase 2 clinical trial of the company's lead compound, RLY5016. These data were presented by Dr. Bertram Pitt, Professor of Medicine Emeritus, Division of Medicine at the University of Michigan School of Medicine, during the Late-Breaking Clinical Trials Session in an oral presentation titled "The PEARL-HF (Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Dose To Evaluate the Effects of RLY5016 in Heart Failure Patients) Trial" at the 14th Annual Scientific Meeting of the Heart Failure Society of America held in San Diego, CA September 13-15, 2010.
More than half of people with acute COVID-19 infection continue to have persistent fatigue 10 weeks after their initial illness, according to a new study published November 9 in the open-access journal PLOS ONE by Liam Townsend of Trinity College Dublin, Ireland and colleagues.
Artel Thorpe Sr. of Jackson, Tennessee, recently became the first person in the United States to undergo a new, less invasive surgical technique for implanting a left ventricular assist device (LVAD) heart pump since it was granted Federal Drug Administration approval on July 11.
District of Columbia Mayor Anthony A. Williams today announced the launch of a comprehensive community outreach campaign to encourage annual child health assessments and immunizations.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark R Keane, MD 341 Saint Johns Way, Lewiston, ID 83501-2436 Ph: () - | Dr Mark R Keane, MD 415 6th St, Lewiston, ID 83501-2431 Ph: (208) 750-7474 |
News Archive
St. Jude Medical, Inc., a global medical device company, today reported sales and net earnings for the second quarter ended July 3, 2010.
Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced positive results from the company's PEARL-HF study, a Phase 2 clinical trial of the company's lead compound, RLY5016. These data were presented by Dr. Bertram Pitt, Professor of Medicine Emeritus, Division of Medicine at the University of Michigan School of Medicine, during the Late-Breaking Clinical Trials Session in an oral presentation titled "The PEARL-HF (Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Dose To Evaluate the Effects of RLY5016 in Heart Failure Patients) Trial" at the 14th Annual Scientific Meeting of the Heart Failure Society of America held in San Diego, CA September 13-15, 2010.
More than half of people with acute COVID-19 infection continue to have persistent fatigue 10 weeks after their initial illness, according to a new study published November 9 in the open-access journal PLOS ONE by Liam Townsend of Trinity College Dublin, Ireland and colleagues.
Artel Thorpe Sr. of Jackson, Tennessee, recently became the first person in the United States to undergo a new, less invasive surgical technique for implanting a left ventricular assist device (LVAD) heart pump since it was granted Federal Drug Administration approval on July 11.
District of Columbia Mayor Anthony A. Williams today announced the launch of a comprehensive community outreach campaign to encourage annual child health assessments and immunizations.
› Verified 9 days ago
Susanne Choby, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 415 6th St, Lewiston, ID 83501 Phone: 208-799-5700 | |
Dr. Arnold Kadrmas, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 415 6th St, Lewiston, ID 83501 Phone: 208-743-2511 Fax: 208-799-5554 | |
Dr. William C Mankel, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 415 6th St, Lewiston, ID 83501 Phone: 208-743-2511 Fax: 208-799-5554 | |
Thadeus B Koontz, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 428 6th Ave, Lewiston, ID 83501 Phone: 208-750-7462 | |
Jean K Thomas, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 415 6th St, Lewiston, ID 83501 Phone: 208-750-7474 Fax: 208-799-5729 | |
Dr. Natasha Vanessa Demattos, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3326 4th St, Suite 6, Lewiston, ID 83501 Phone: 208-746-2223 |